Gain Therapeutics, Inc. (GANX)
NASDAQ: GANX · Real-Time Price · USD
1.685
+0.025 (1.51%)
Jul 17, 2026, 2:44 PM EDT - Market open
Gain Therapeutics Market Cap
Gain Therapeutics has a market cap or net worth of $71.87 million as of July 17, 2026. Its market cap has increased by 28.33% in one year.
Market Cap
71.87M
Enterprise Value
55.37M
1-Year Change
28.33%
Ranking
Category
Stock Price
$1.69
ChartMarket Cap Chart
Since the IPO on March 18, 2021, Gain Therapeutics's market cap has decreased from $124.64M to $71.87M, a decrease of -42.34%. That is a compound annual growth rate of -9.81%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 17, 2026 | 71.87M | -41.97% |
| Dec 31, 2025 | 123.85M | 116.16% |
| Dec 31, 2024 | 57.29M | 16.03% |
| Dec 29, 2023 | 49.38M | 32.75% |
| Dec 30, 2022 | 37.19M | -42.34% |
| Dec 31, 2021 | 64.51M | -48.25% |
| Mar 18, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Atara Biotherapeutics | 76.41M |
| Acrivon Therapeutics | 76.19M |
| Alps Group | 74.88M |
| LeonaBio | 74.30M |
| Annovis Bio | 74.24M |
| OKYO Pharma | 72.42M |
| MindWalk Holdings | 71.45M |
| MediciNova | 70.14M |